Screener
Xenon Pharmaceuticals XENE Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Xenon Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: Xenon Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338244
FAQ
- What is Xenon Pharmaceuticals's current ratio?
- Xenon Pharmaceuticals (XENE) reported current ratio of 21× in Q2 2026.
- How has Xenon Pharmaceuticals's current ratio changed year-over-year?
- Xenon Pharmaceuticals's current ratio increased by 38.8% year-over-year, from 15.1× to 21×.
- What is the long-term trend for Xenon Pharmaceuticals's current ratio?
- Over 5 years (2020 to 2025), Xenon Pharmaceuticals's current ratio has grown at a 1.8% compound annual growth rate (CAGR), from 12.3× to 13.4×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Xenon Pharmaceuticals's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude